Megan Woodard
Registered Nurse · Noblesville, INNPI 1740766138
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 30.8% of the total. Reporting peaked in 2023 at $790 and has fallen 57.2% since, to $338 in 2025. Among registered nurse clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$519
- Novo Nordisk$275
- Exeltis, USA Inc.$257
- Pfizer$209
- Therapeuticsmd, Inc.$198
- plus $817 from 12 others
What the payments were for
- Food & beverage$3,288100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 80 | $1,014 |
| Astellas Pharma US Inc | 21 | $519 |
| Novo Nordisk | 10 | $275 |
| Exeltis, USA Inc. | 16 | $257 |
| Pfizer | 12 | $209 |
| Therapeuticsmd, Inc. | 15 | $198 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $172 |
| Biohaven Pharmaceuticals, Inc. | 3 | $143 |
| Antares Pharma, Inc. | 7 | $106 |
| Lilly USA, LLC | 7 | $97 |
| Halozyme Inc | 4 | $69 |
| Sun Pharmaceutical Industries Inc. | 3 | $64 |
| Millicent US Inc | 3 | $56 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Shield Therapeutics Inc | 1 | $14 |
| Acerus Pharmaceuticals Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$237
- Veozah$125
- Wegovy$124
How this compares
$3,288 in reported general payments places this provider in the 95th percentile of 63 registered nurse providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 67 | $2,640 |
| Norethindrone Acetate | 14 | $1,417 |
| Estradiol | 28 | $824 |
| Spironolactone | 48 | $611 |
| Eszopiclone | 17 | $386 |
| Tramadol Hcl | 13 | $376 |
| Fluconazole | 17 | $218 |
| Levothyroxine Sodium | 17 | $71 |
| Anastrozole | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Other registered nurse in Noblesville
- Emily GroveNoblesville$548
- Brook WhitakerBloomington$9K
- Keri LoweMuncie$8K
- Alicia RothchildMerrillville$3K
- Tera HornbeckLafayette$2K
- Lauren HerrEvansville$2K
- Meagan HansonIndianapolis$2K
- Travis McPikeBainbridge$1K
- Shana PorterIndianapolis$1K
- Kristie TidrickLafayette$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.